Results 71 to 80 of about 81,709 (149)

The interaction between kynurenine pathway, suicidal ideation and augmentation therapy with minocycline in patients with treatment-resistant depression. [PDF]

J Psychopharmacol, 2023
Nettis MA, Lombardo G, Hastings C, Zajkowska Z, Mariani N, Nikkheslat N, Sforzini L, Worrell C, Begum A, Brown M, Cleare AJ, Young AH, Pariante CM, Mondelli V.   +13 more
europepmc   +1 more source

Analysis of medical malpractice litigation following vertebral augmentation therapy in China from 2008 to 2018. [PDF]

Medicine (Baltimore), 2022
Hu D, Liu H, Yuan B, Gu S, Xu K, Song F, Xiao S.   +6 more
europepmc   +1 more source

Efficacy of Antipsychotic Augmentation Therapy in Treatment-Resistant Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Shahtou A, Omara HR, Qari SA, Alqahtani RS, Alnasyan ZS, Alotaibi AE, Ali AA, Alabdulrahim JM, Naser SA, Asad N, Bagabas L, Jilani SA, Metwaly AS.   +12 more
europepmc   +1 more source

Mitigating the Risk of Adverse Effects Related to Augmentation Therapy for Resistant Major Depressive Disorder: A Case Report. [PDF]

Medicina (Kaunas), 2022
Amundson CJ, Knight R, Ybarra GM, Turgeon J, Bingham JM.   +4 more
europepmc   +1 more source

Gene augmentation therapy restores vision and preserves photoreceptors in a mouse model of CNGA1-retinitis pigmentosa. [PDF]

Commun Med (Lond)
Wu Y, Zhao T, Wang Y, Zhang T, Hang C, Wang Y, Liu Y, Chen Z, Chen J, Li T, Sun J, Jia H, Zhang L, Wang F, Wan X, Sun X.   +15 more
europepmc   +1 more source

Cortical Visual Mapping following Ocular Gene Augmentation Therapy for Achromatopsia. [PDF]

J Neurosci, 2021
McKyton A, Averbukh E, Marks Ohana D, Levin N, Banin E.   +4 more
europepmc   +1 more source

Non-invasive brain stimulation augmentation therapy for treatment-resistant schizophrenia: a systematic review and network meta-analysis. [PDF]

EClinicalMedicine
Wei Y, Lorenz C, Siafis S, Schneider-Thoma J, Kim DD, Wu H, Nomura N, Dong S, Furukawa Y, Zhu Y, Bighelli I, Hansen WP, Vogelmann U, Strube W, Li C, Davis JM, Smith RC, Salanti G, Padberg F, Leucht S.   +19 more
europepmc   +1 more source

Self-administration of augmentation therapy for alpha 1-antitrypsin deficiency. [PDF]

IJTLD Open
Vianello A, Lococo S, Corda L, Torrazza M, Zuccarini G, Baderna P, Cinetto F, Bargagli E, Confalonieri P, Sanduzzi Zamparelli S, Bertagna De Marchi L, Molena B, Lionello F, Caminati M, Guarnieri G.   +14 more
europepmc   +1 more source

Fine-tuning FAM161A gene augmentation therapy to restore retinal function

, 2023
Arsenijevic Y, Chang N, Mercey O, Fersioui YE, Koskiniemi-Kuendig H, Joubert C, Bemelmans A, Rivolta C, Banin E, Sharon D, Guichard P, Hamel V, Kostic C.   +12 more
europepmc   +1 more source

Mood Stabilizers and Antipsychotics for Acute Mania: Systematic Review and Meta-Analysis of Augmentation Therapy vs Monotherapy From the Perspective of Time to the Onset of Treatment Effects. [PDF]

Int J Neuropsychopharmacol, 2022
Tajika A, Hori H, Iga JI, Koshikawa Y, Ogata H, Ogawa Y, Watanabe K, Kato T, Matsuo K, Kato M.   +9 more
europepmc   +1 more source